respiratori
tract
infect
frequent
encount
ill
western
world
infect
encompass
common
cold
influenza
may
manifest
wide
varieti
symptomsfrom
slight
nasal
stuffi
itch
throat
pulsat
headach
chesti
cough
fever
even
mild
episod
cold
flu
patient
seek
relief
acut
symptom
gener
discomfort
experienc
data
nation
institut
allergi
infecti
diseas
nation
institut
health
estim
one
billion
case
cold
experienc
unit
state
everi
year
total
million
visit
doctor
approxim
million
day
absenc
school
well
million
day
restrict
activ
attribut
cold
flu
overal
cost
ill
amount
us
billion
term
econom
burden
cold
flu
rank
leagu
hypertens
stroke
chronic
obstruct
pulmonari
diseas
cold
flu
caus
wide
varieti
virus
rhinoviru
coronaviru
respiratori
syncyti
viru
rsv
metapneumoviru
bocca
viru
final
parainfluenza
influenza
virus
often
difficult
clinic
differenti
cold
flu
absenc
viral
test
imposs
identifi
caus
organ
even
influenza
epidem
clinic
identifi
flulik
ill
caus
influenza
virus
howev
infect
parainfluenza
rsv
even
common
viru
caus
cold
rhinoviru
produc
substanti
morbid
mortal
complic
respiratori
tract
infect
includ
otiti
media
sinus
bronchiti
bronchiol
pneumonia
cold
known
exacerb
asthma
especi
children
vaccin
provid
effect
mean
combat
infect
caus
influenza
viru
current
pharmacolog
agent
protect
respiratori
virus
develop
specif
prophylact
cold
flu
hamper
multipl
virus
propens
mutat
altern
approach
support
bodi
immun
mechan
fall
back
principl
human
organ
abl
defend
natur
virus
bacteria
echinacea
purpurea
claim
uniqu
therapeut
role
standardis
echinacea
product
carri
statu
regist
medicin
approv
indic
cover
support
immun
resist
andor
prevent
acut
treatment
cold
flu
symptom
recent
research
special
extract
echinacea
purpurea
echinaforc
intensifi
mainli
consequ
experi
newli
occur
respiratori
virus
influenza
virus
coronavirus
novel
understand
pharmacolog
mechan
respiratori
infect
known
weak
avail
therapi
echinaforc
standardis
alcohol
extract
freshli
harvest
echinacea
purpurea
vogel
bioforc
ag
roggwil
switzerland
grown
recycl
seed
organ
cultiv
echinaforc
consist
herb
extract
root
extract
predomin
virus
cold
flu
infect
repeatedli
outlin
involv
episod
three
major
scientif
articl
report
potenc
echinacea
broadli
inhibit
seri
respiratori
virus
vitro
antivir
activ
found
influenza
ab
soiv
rsv
herp
simplex
viru
hsv
recent
yet
unpublish
research
data
indic
coronavirus
parainfluenza
virus
also
sensit
extract
reinforc
theori
echinaforc
broadli
block
membran
virus
prof
pleschka
univers
giessen
germani
found
extract
modifi
structur
surfac
receptor
influenza
virus
haemagglutinin
requir
entri
cell
data
suggest
echinaforc
interf
viru
replic
process
earliest
possibl
step
cellular
infect
therebi
prevent
infect
intracellular
replic
howev
affect
extract
higher
concentr
even
continu
passag
influenza
virus
presenc
echinaforc
result
emerg
resist
influenza
strain
wherea
cultur
virus
presenc
neuraminidas
inhibitor
tamiflu
rapidli
gener
drugresist
strain
intriguingli
tamiflu
resist
influenza
virus
remain
suscept
echinaforc
immunolog
effect
echinaforc
intact
immun
system
prerequisit
success
immun
defenc
seen
patient
aid
even
opportunist
infect
lead
death
howev
case
cold
flu
recent
argu
simpli
boost
immun
system
might
last
thing
want
context
dr
ritchi
univers
london
uk
group
aim
explor
immunolog
effect
prophylact
treatment
echinaforc
runin
phase
day
baselin
subject
began
take
oral
dose
echinaforc
day
blood
collect
everi
day
immunolog
paramet
measur
ex
vivostimul
use
seblp
even
day
treatment
extract
reduc
inflammatori
protein
tumour
necrosi
factor
tnf
interleukin
il
total
popul
interestingli
effect
antivir
interferon
ifn
chemotact
molecul
monocyt
chemoattract
protein
mcp
depend
respect
constitut
runin
phase
baselin
subject
low
initi
product
baselin
echinacea
treatment
induc
addit
format
signal
substanc
comparison
baselin
contrast
increas
subject
high
initi
format
factor
baselin
select
support
immun
reaction
also
observ
subject
report
increas
stress
higher
suscept
cold
infect
past
clinic
trial
indic
echinacea
support
lowrun
immun
system
phase
increas
stress
suscept
cold
infect
also
show
wellperform
immun
system
overstimul
echinacea
efficaci
safeti
echinaforc
longterm
prevent
cold
flu
latest
randomis
doubleblind
placebocontrol
clinic
trial
investig
safeti
efficaci
echinaforc
prophylaxi
month
nasal
secret
particip
acut
cold
taken
analys
respiratori
virus
clinic
trial
subject
repres
largest
studi
ever
echinacea
carri
common
cold
centr
cardiff
univers
uk
regard
advers
event
advers
drug
reaction
laboratori
blood
paramet
final
physician
particip
assess
toler
echinaforc
found
noninferior
placebo
previous
report
safeti
concern
induct
allerg
reaction
leucopenia
autoimmun
diseas
observ
echinacea
treatment
consider
cold
episod
episod
day
cold
occur
placebo
episod
requir
pain
medic
p
confirm
viral
infect
reduc
echinaforc
especi
influenza
rsv
parainfluenza
coronaviru
infect
maxim
prevent
seen
subject
recur
cold
infect
episod
observ
subject
placebo
reduc
episod
subject
echinaforc
correspond
ratio
frequenc
recur
infect
p
differ
reach
statist
signific
recur
episod
virusposit
nasal
sampl
went
infect
subgroup
n
taken
least
recommend
dose
report
total
cold
episod
episod
day
take
placebo
comparison
cold
episod
episod
day
echinaforc
correspond
highli
signific
differ
cold
episod
episod
day
respect
p
prevent
effect
studi
group
report
stress
stress
individu
select
score
exceed
point
perceiv
stress
scale
develop
cohen
cold
episod
episod
day
placebotr
group
significantli
higher
p
respect
similar
result
seen
suscept
individu
two
episod
cold
per
year
poor
sleep
h
sleep
final
smoke
although
last
popul
small
subject
newli
report
result
confirm
echinaforc
support
immun
resist
parallel
act
directli
seri
virus
appear
effect
therapeut
approach
work
level
human
host
also
act
infecti
organismsal
highli
accept
toler
cold
flu
present
signific
interfer
individu
product
physic
fit
wellb
vital
also
burden
whole
health
care
system
infect
potenti
lead
complic
pneumonia
bronchiti
sinus
exacerb
exist
asthma
chronic
obstruct
pulmonari
diseas
copd
associ
substanti
morbid
mortal
therapeut
point
view
cold
flu
remain
mysteri
real
challeng
efficaci
dietari
supplement
includ
vitamin
zinc
uncertain
neuraminidas
inhibitor
vaccin
ineffect
infect
outsid
influenza
epidem
light
frequent
offlabel
use
medicin
inappropri
use
antibiot
increas
antibiot
drug
resist
rate
worldwid
need
altern
clinic
proven
effect
remedi
prevent
respiratori
tract
infect
urgent
need
research
evid
echinaforc
relev
clinic
practic
follow
way
repres
one
solut
prevent
acut
treatment
cold
flu
broad
spectrum
antivir
activ
support
modul
immun
activ
especi
stress
shown
safe
medicin
product
combin
immunomodulatori
antivir
effect
open
novel
therapeut
possibl
area
use
echinacea
especi
echinaforc
recommend
use
divid
three
therapeut
scenario
longterm
prevent
throughout
winter
season
clinic
perspect
longterm
prevent
use
advis
individu
suscept
cold
flu
histori
three
infect
per
year
echinaforc
also
recommend
longterm
use
children
elderli
well
suffer
copd
asthma
patient
smokerspeopl
consequ
cold
flu
sever
shortterm
prevent
week
month
time
increas
stress
poor
sleep
benefici
support
immun
resist
echinacea
balanc
neg
effect
immun
system
situat
shortterm
prevent
use
echinacea
week
appli
peak
period
viral
outbreak
one
surround
peopl
cold
infect
public
place
offic
well
higher
level
activ
virus
public
surfac
handrail
public
telephon
etc
probabl
repres
import
scenario
shortterm
prevent
use
echinacea
proven
antivir
effect
acut
treatment
first
symptom
prevent
may
interest
select
group
peopl
acut
treatment
cold
flu
advantag
everyon
crucial
administ
echinacea
earliest
possibl
opportun
best
present
first
sign
symptom
usual
itchi
throat
sneez
block
inflamm
viral
replic
stage
develop
cold
symptom
limit
lead
reduc
need
nasal
decongest
pain
medic
cough
medicin
unnecessari
prescript
antibiot
point
view
clinic
practic
clear
echinacea
abl
fill
therapeut
gap
treatment
cold
flu
uniqu
way
review
increas
confid
echinaforc
effect
three
indic
longterm
shortterm
prevent
acut
treatment
overal
solut
manag
cold
flu
strong
argument
clinician
healthcar
profession
recommend
echinacea
especi
echinaforc
one
remedi
present
everi
home
readili
avail
one
take
earli
action
cold
flu
virus
strike
